Azacitidine Followed By Intensive Induction/Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML): Results from the Randomized AML-AZA Trial of the Study Alliance Leukemias (SAL)

Mueller-Tidow, Carsten and Tschanter, Petra and Krug, Utz and Goellner, Stefanie and Roellig, Christoph and Thiede, Christian and Koschmieder, Anja and Dugas, Martin and Gerss, Joachim and Butterfass-Bahloul, Trude and Wagner, Ruth and Krause, Stefan W. and Kaiser, Ulrich and Kunzmann, Volker and Steffen, Bjoern and Noppeney, Richard and Herr, Wolfgang and Baldus, Claudia D. and Schmitz, Norbert and Goetze, Katharina and Reichle, Albrecht and Kaufmann, Martin and Neubauer, Andreas and Schaefer-Eckart, Kerstin and Haenel, Mathias and Peceny, Rudolf and Bea, Haack and Meredith, Lilly and Frickhofen, Norbert and Kiehl, Michael G. and Giagounidis, Aristoteles A. N. and Goerner, Martin and Repp, Roland and Naumann, Ralph and Link, Hartmut and Kiani, Alexander and Koschmieder, Steffen and Bruemmendorf, Tim H. and Serve, Hubert and Ehninger, Gerhard and Berdel, Wolfgang E. (2014) Azacitidine Followed By Intensive Induction/Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML): Results from the Randomized AML-AZA Trial of the Study Alliance Leukemias (SAL). BLOOD, 124 (21): 946. ISSN 0006-4971, 1528-0020

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 13 Aug 2020 14:31
Last Modified: 13 Aug 2020 14:31
URI: https://pred.uni-regensburg.de/id/eprint/9059

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.